Richard P. Slaughter Associates’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-33,551
Closed -$3.34M 148
2024
Q4
$3.34M Sell
33,551
-1,303
-4% -$134K 0.75% 30
2024
Q3
$3.96M Buy
34,854
+4,766
+16% +$566K 0.92% 25
2024
Q2
$3.72M Buy
30,088
+875
+3% +$113K 0.88% 27
2024
Q1
$3.85M Sell
29,213
-3,100
-10% -$382K 0.92% 23
2023
Q4
$3.52M Buy
32,313
+18,781
+139% +$1.95M 0.87% 24
2023
Q3
$1.39M Buy
13,532
+1,091
+9% +$118K 0.37% 80
2023
Q2
$1.44M Buy
+12,441
New +$1.41M 0.41% 70

Other funds holding MRK

Richard P. Slaughter Associates's MRK Position: Q1 2025 in Review

Richard P. Slaughter Associates sold out of Merck (MRK) in Q1 2025, closing a stake of 33,551 shares — an estimated $3.34M sold.

Richard P. Slaughter Associates first reported a position in MRK in Q2 2023 and held it in 7 quarters. The position peaked at $3.96M in Q3 2024. 3,454 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Richard P. Slaughter Associates reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Richard P. Slaughter Associates sold 33,551 Merck shares in Q1 2025, an estimated $3.34M.
  • Richard P. Slaughter Associates first reported a position in Merck in Q2 2023 and held it in 7 quarters.
  • Richard P. Slaughter Associates's Merck position peaked at $3.96M in Q3 2024.
  • 3,454 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Richard P. Slaughter Associates's 13F filing for Q1 2025, filed 10 Apr 2025.